2014 - PCMH4D: Difference between revisions

From PCMH
Jump to navigation Jump to search
(Created page with "[http://pcmh.pcc.com/index.php/2014_Main Back to PCMH Resources Page] [http://pcmh.pcc.com/index.php/2014_-_PCMH4C << Move to previous PCMH element - 4C] [http://pcmh.pcc.co...")
 
No edit summary
Line 9: Line 9:
=4.D.1 More than 50 percent of eligible prescriptions written by the practice are compared to drug formularies and electronically sent to pharmacies. =
=4.D.1 More than 50 percent of eligible prescriptions written by the practice are compared to drug formularies and electronically sent to pharmacies. =


{| border = "1"
PCC eRx has a built in capability to query for drug formularies.  Use the stage 2 or modified stage 2 MU report and refer to the "Electronic Prescribing (Without Controlled Substances)" measure for this factor.
! style="background:#8facd9; width:40%;" |'''Description'''
! style="background:#8facd9; width:20%;" |'''Example/Screenshot/Documentation'''
! style="background:#8facd9; width:20%;" |'''Source'''
! style="background:#8facd9; width:20%;" |'''Date Added'''
|-
|}


=4.D.2 Enters electronic medication orders in the medical record for more than 60 percent of medications. =
=4.D.2 Enters electronic medication orders in the medical record for more than 60 percent of medications. =


{| border = "1"
Use the stage 2 or modified stage 2 MU report and refer to the "CPOE (Medications)" measure for this factor.  All medications ordered via PCC eRx are electronically recorded in the medical record, so all practices should achieve 100% for this measure.
! style="background:#8facd9; width:40%;" |'''Description'''
! style="background:#8facd9; width:20%;" |'''Example/Screenshot/Documentation'''
! style="background:#8facd9; width:20%;" |'''Source'''
! style="background:#8facd9; width:20%;" |'''Date Added'''
|-
|This is referring to the "CPOE for Medication Orders" Meaningful Use measure, so refer to the PCC EHR MU report for this data.||||PCC EHR||07/25/13
|-
|}


=4.D.3 Performs patient-specific checks for drug-drug and drug-allergy interactions. =
=4.D.3 Performs patient-specific checks for drug-drug and drug-allergy interactions. =
'''PCC EHR users can receive auto credit for this factor'''


{| border = "1"
{| border = "1"
Line 44: Line 32:


=4.D.4 Alerts prescribers to generic alternatives. =
=4.D.4 Alerts prescribers to generic alternatives. =
'''PCC EHR users can receive auto credit for this factor'''


{| border = "1"
{| border = "1"

Revision as of 21:45, 1 December 2015

Back to PCMH Resources Page

<< Move to previous PCMH element - 4C

>> Move to next PCMH element - 4E

The practice uses an electronic prescription system with the following capabilities:

4.D.1 More than 50 percent of eligible prescriptions written by the practice are compared to drug formularies and electronically sent to pharmacies.

PCC eRx has a built in capability to query for drug formularies. Use the stage 2 or modified stage 2 MU report and refer to the "Electronic Prescribing (Without Controlled Substances)" measure for this factor.

4.D.2 Enters electronic medication orders in the medical record for more than 60 percent of medications.

Use the stage 2 or modified stage 2 MU report and refer to the "CPOE (Medications)" measure for this factor. All medications ordered via PCC eRx are electronically recorded in the medical record, so all practices should achieve 100% for this measure.

4.D.3 Performs patient-specific checks for drug-drug and drug-allergy interactions.

PCC EHR users can receive auto credit for this factor

Description Example/Screenshot/Documentation Source Date Added
Document describing how PCC eRx checks for drug-drug and drug-allergy interactions Interaction checking in PCC eRx PCC EHR 07/07/14
Your PCC eRX provides these alerts eRX Alerts PCC EHR 03/25/13

4.D.4 Alerts prescribers to generic alternatives.

PCC EHR users can receive auto credit for this factor

Description Example/Screenshot/Documentation Source Date Added
Document showing how PCC eRx shows alerts for generic alternatives Alerts for generic alternatives in PCC eRx PCC eRx 07/07/14